Wrap up: dvm360 announces 2026 Veterinary Hero award winners, and other news

Happy Friday dvm360 readers! Everyone at dvm360 is so excited to share that we have officially announced the winners of this year’s Veterinary Heroes Awards! For the last 5 years, dvm360 has honored the veterinary community by awarding members of the industry, who have been nominated by their peers, for all their hard work and dedication that is making the industry a better place for professionals, industry partners, clients, and most important, patients. You can see a full list of our winners here!

Besides our Veterinary Heroes being announced, here is some other news that was popular this week on dvm360.com:

• The FDA announced this week that it issued an Emergency Use Authorization (EUA) for generic Nitenpyram Tablets for treating myiasis caused by New World screwworm in dogs, cats, puppies, and kittens, that are at least 4 weeks old and 2 pounds, making this the first generic animal drug to receive EUA for use against NWS.
• When it comes to the clients at your clinic, are you sabotaging their visits? In an article written by Jill Clark, DVM, she explores the way that veterinary clinics could be causing clients to not return, and ways that they can fix the problem if it does lie within the walls of your clinic.
• dvm360 had multiple podcast episodes drop this week! On the Vet Blast Podcast presented by dvm360, Adam Christman, DVM, MBA, welcomed Debra Hamilton, JD, on the show to talk about ways veterinary teams can use communication to defuse any conflict with clients. Then, on this week’s The Resilient Vet: Mind and Body Strategies for Success, cohosts Aaron Shaw, OTR/L, CHT, CSCS, and Jennifer Edwards, DVM, ACC, CPC, ELI-MP, talked more about chronic over-accommodation and the impact it has on veterinary clinics.
• Hill’s Pet Nutrition announced this week it has 2 new therapeutic diet options for dogs and cats with concurrent chronic kidney disease and dermatologic or gastrointestinal sensitivities to provide veterinary professionals and clients the option to support a population of animals that can be difficult to manage.
• Pimobendan Chewable Tablets (Cronus Pharma LLC) have officially launched in the US veterinary market and is currently available for purchase. This is the first generic bioequivalent to Vetmedin (Boehringer Ingelheim Animal Health)
• And more!